CN1745779A - Chinese medicine for treating angiitis and phlebitis etc. thromboembolia disease - Google Patents
Chinese medicine for treating angiitis and phlebitis etc. thromboembolia disease Download PDFInfo
- Publication number
- CN1745779A CN1745779A CN 200410043859 CN200410043859A CN1745779A CN 1745779 A CN1745779 A CN 1745779A CN 200410043859 CN200410043859 CN 200410043859 CN 200410043859 A CN200410043859 A CN 200410043859A CN 1745779 A CN1745779 A CN 1745779A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- pollen
- phlebitis
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of ointment for treating vasculitis, phlebitis, phlebeurysma, peripheral neurtitis, pile, burn, scald, etc is prepared from 7 Chinese-medicinal materials including dahurian angelica root, pollen, red peony root, red sage root, etc through grinding and mixing the powder with vaseline.
Description
Technical field: the present invention relates to Chinese medicine, particularly the Chinese medicine of the inaccessible disease of thrombosis such as vasculitis, phlebitis, varicosis.
Background technology: be used for the treatment of vasculitis at present, phlebitis, varicosis, thunder Loews disease, the significant medicine that also is of no curative effect of diseases such as peripheral nerve inflammation, it is all very painful to suffer from this sick people, the patient who is in a bad way also needs amputation, done multiple effort in order to address this problem people, the plurality of Chinese prescription has been proposed, as Chinese patent: " 00129961; 1 " the technology that one key name is called " a kind of vasculitic medicated powder of treatment and preparation method " number is disclosed, this medicine has certain effect to alleviating lighter symptom, then be of no curative effect for the patient with severe symptoms, addressing this problem becomes urgent need.
The content of invention: overcome the deficiency that prior art exists, propose that a kind of therapeutic effect is splendid, short treating period, the Chinese medicine that can effect a radical cure diseases such as vasculitis, phlebitis, varicosis, thunder Loews disease, peripheral nerve inflammation that expense is low.This Chinese medicine is made of following composition: Radix Et Rhizoma Rhei, the Radix Angelicae Dahuricae, pollen, Radix Paeoniae Rubra, Pollen Typhae, Radix Salviae Miltiorrhizae, Olibanum; The weight proportion of its each composition is: the 10-20 of Radix Et Rhizoma Rhei part, Radix Angelicae Dahuricae 10-20 part, pollen 10-20 part, Radix Paeoniae Rubra 10-20 part, Pollen Typhae 10-20 part, Radix Salviae Miltiorrhizae 10-20 part, Olibanum 10-20 part.Its production technology is: Radix Et Rhizoma Rhei, the Radix Angelicae Dahuricae, pollen, Radix Paeoniae Rubra, Pollen Typhae, Radix Salviae Miltiorrhizae, Olibanum seven flavor medicine are ground to form 100 purpose smalls, and mix homogeneously adding vaseline is made ointment and is got final product.Chinese medicine of the present invention is owing to contain Radix Et Rhizoma Rhei, and the energy diuretic has the removing blood stasis and activating blood flow function, and subcutaneous tissue is discharged sepage, accelerates hypodermic recovery; Owing to contain pollen, have multivitamin and trace element, can remove the too much free radical of human body, keep cell activity and vigor, locate into metabolism; Contain the Radix Angelicae Dahuricae, have that cold expelling is sensible, an effect of wind-expelling pain-stopping, detumescence and apocenosis.Contain pollen, contain Radix Paeoniae Rubra, have the effect of clearing away heat and cooling blood, stasis-dispelling and pain-killing.Contain Pollen Typhae, the effect of have hemostasis, invigorating blood circulation.Contain Radix Salviae Miltiorrhizae, have the effect of blood circulation promoting and blood stasis dispelling, removing heat from blood eliminating carbuncle.Contain Olibanum, have the effect of promoting blood circulation and stopping pain, granulation promoting.The result of above-mentioned every medicine comprehensive function makes Chinese medicine of the present invention have blood circulation promoting and blood stasis dispelling, dredge the meridian passage, puies forward the function of analgesic, the anti-inflammatory analgesic of poison, removing the necrotic tissue and promoting granulation, and disease effects such as treatment vasculitis, phlebitis, varicosis are splendid, short treating period, expense are low.
The specific embodiment: get the 10g of Radix Et Rhizoma Rhei, Radix Angelicae Dahuricae 10g, pollen 10g, Radix Paeoniae Rubra 10g, Pollen Typhae 10g, Radix Salviae Miltiorrhizae 10g, Olibanum 20g, grind to form 100 purpose smalls, mix homogeneously adds vaseline and makes ointment promptly.
Get the 20g of Radix Et Rhizoma Rhei, Radix Angelicae Dahuricae 20g, pollen 20g, Radix Paeoniae Rubra 20g, Pollen Typhae 20g, Radix Salviae Miltiorrhizae 20g, Olibanum 10g, grind to form 100 purpose smalls, mix homogeneously adds vaseline and makes ointment promptly.
Using method: medicine for external use is applied to the illing skin surface, a 4g, 1 time on the one.
In order to estimate the clinical medicine safety of Chinese medicine of the present invention, it has been carried out toxicity test research, be reported as follows:
1. be subjected to test product: a kind of Chinese medicine every day for the treatment of the inaccessible diseases of thrombosis such as vasculitis, phlebitis 1 time, each 4 grams.
2. experimental animal: the white mice of Kunming kind, body weight 18-22 gram, male and female dual-purpose.
3. the preparation of dosage and test drug: get a kind of Chinese medicine 4 grams for the treatment of the inaccessible diseases of thrombosis such as vasculitis, phlebitis, put and add the 10.0ml distilled water in the mortar and be uniformly dispersed, make solution.Administering mode is a gastric infusion.
One, the mensuration of median lethal dose(LD 50)
Get 9 of mices, divide three groups, but fail to find out the dosage of 100% animal dead.
Select 50 of the healthy mices of body weight 20 ± 2g for use, male and female half and half are divided into five groups at random, an oral administration gavage administration, and dosage is by geometric progression, and maximum dose level calculates with the maximum volume that can accept.Observed 7 days none death as a result after the administration.
Two, mtd test
Select 20 of healthy mices, male and female half and half, normally raise 1 after, administration is 1 time in 24 hours, observes continuously 7, does not see untoward reaction and death condition, can think the oral avirulence of this medicine.The maximum tolerated dose multiple is calculated as follows:
If use every day by the adult; Consumption 4 grams calculate, and the result is 240 times of normal clinical dosage, illustrate that a kind of Chinese medicine for the treatment of the inaccessible disease of thrombosis such as vasculitis, phlebitis has safety.
A kind of Chinese medicine clinical summary for the treatment of the inaccessible disease of thrombosis such as vasculitis, phlebitis
One group to the statistics in the patients clinical observations of diseases such as vasculitis, phlebitis, varicosis this organizes 5% case for observing the patient of treatment.Man's 43 examples wherein, women 16 examples, age 40-50 year 10 examples, 51-60 year 30 examples, 19 examples more than 61 years old, wherein Therapeutic Method is the patient to be divided into two groups at random, 39 examples are organized in treatment, use Chinese medicine of the present invention, every day 1 time, each 4 grams, 30 days is a course of treatment.Matched group 20 examples are taken other medicine, and 30 days is a course of treatment, all do inspection before and after the treatment, and the result shows that the treatment group effective percentage of taking Chinese medicine of the present invention is 98%, and matched group does not have obvious effects.
Claims (2)
1, a kind of Chinese medicine for the treatment of the inaccessible disease of thrombosis such as vasculitis, phlebitis is characterized in that this Chinese medicine is made of following composition: Radix Et Rhizoma Rhei, the Radix Angelicae Dahuricae, pollen, Radix Paeoniae Rubra, Pollen Typhae, Radix Salviae Miltiorrhizae, Olibanum; The weight proportion of its each composition is: the 10-20 of Radix Et Rhizoma Rhei part, Radix Angelicae Dahuricae 10-20 part, pollen 10-20 part, Radix Paeoniae Rubra 10-20 part, Pollen Typhae 10-20 part, Radix Salviae Miltiorrhizae 10-20 part, Olibanum 10-20 part.
2, the Chinese medicine of the inaccessible disease of thrombosis such as treatment vasculitis as claimed in claim 1, phlebitis, it is characterized in that its production technology is: Radix Et Rhizoma Rhei, the Radix Angelicae Dahuricae, pollen, Radix Paeoniae Rubra, Pollen Typhae, Radix Salviae Miltiorrhizae, Olibanum seven flavor medicine are ground to form 100 purpose smalls, and mix homogeneously adding vaseline is made ointment and is got final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100438597A CN100360154C (en) | 2004-09-10 | 2004-09-10 | Chinese medicine for treating angiitis and phlebitis etc. thromboembolia disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100438597A CN100360154C (en) | 2004-09-10 | 2004-09-10 | Chinese medicine for treating angiitis and phlebitis etc. thromboembolia disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1745779A true CN1745779A (en) | 2006-03-15 |
CN100360154C CN100360154C (en) | 2008-01-09 |
Family
ID=36165597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100438597A Expired - Fee Related CN100360154C (en) | 2004-09-10 | 2004-09-10 | Chinese medicine for treating angiitis and phlebitis etc. thromboembolia disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100360154C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103393918A (en) * | 2013-07-25 | 2013-11-20 | 山西省中医药研究院 | Compounded garcinia and radix angelicae ointment for preventing and treating chemotherapeutic phlebitis |
CN104352761A (en) * | 2014-12-10 | 2015-02-18 | 云南省第二人民医院 | Medicine for relieving varicose veins and preparation method thereof |
CN105194256A (en) * | 2015-10-30 | 2015-12-30 | 张先雷 | Traditional Chinese medicine fumigation lotion for treating Raynaud's disease |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1108119A (en) * | 1994-12-28 | 1995-09-13 | 薛连贵 | Traditional Chinese medicinal extract containing Agkistrodon acutus |
CN1174764C (en) * | 2001-05-25 | 2004-11-10 | 赵忠生 | Blood circulation promoting wine |
-
2004
- 2004-09-10 CN CNB2004100438597A patent/CN100360154C/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103393918A (en) * | 2013-07-25 | 2013-11-20 | 山西省中医药研究院 | Compounded garcinia and radix angelicae ointment for preventing and treating chemotherapeutic phlebitis |
CN103393918B (en) * | 2013-07-25 | 2015-01-28 | 山西省中医药研究院 | Compounded garcinia and radix angelicae ointment for preventing and treating chemotherapeutic phlebitis |
CN104352761A (en) * | 2014-12-10 | 2015-02-18 | 云南省第二人民医院 | Medicine for relieving varicose veins and preparation method thereof |
CN105194256A (en) * | 2015-10-30 | 2015-12-30 | 张先雷 | Traditional Chinese medicine fumigation lotion for treating Raynaud's disease |
Also Published As
Publication number | Publication date |
---|---|
CN100360154C (en) | 2008-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1305515C (en) | Chinese medicinal powder and decoction composition for treating cancer | |
CN1308015C (en) | Chinese medicine for curing toothache | |
CN102657785B (en) | Medicinal composition for treating gingivitis | |
CN1583112A (en) | Capsules for nourishing kidney and strengthening yang | |
CN100360154C (en) | Chinese medicine for treating angiitis and phlebitis etc. thromboembolia disease | |
CN101214365B (en) | Chinese medicine composing prescription for treating mastoproliferation | |
CN101983652A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
CN102836338B (en) | Chinese medicament for treating cardia-cerebrovascular diseases | |
CN1259065C (en) | Chinese medicinal preparation for quick bone fracture setting | |
CN101797309A (en) | Traditional Chinese medicine for treating scleriasis and venereal disease | |
CN105362382A (en) | Traditional Chinese medicine composition for treating recurrent oral ulcer and application thereof | |
CN1879722A (en) | A medicine for treating rheumatic arthritis | |
CN101032575A (en) | Chinese traditional medicine for curing angiocardiopathy and cerebrovascular disease | |
CN100577199C (en) | Application of stomachic pill with cyperus and amomum | |
CN100411672C (en) | A medicinal composition for treatment of psoriasis | |
CN110420292A (en) | A kind of Chinese medicine and preparation method thereof for treating headache | |
CN1092968C (en) | Pharmaceuticals for treating outer skin blood vessel diease in cold seasons | |
CN103006995B (en) | Medicine for treating post-dural puncture headache (PDPHA) | |
CN1823960A (en) | Traditional Chinese medicine for treating hemorrhoid | |
CN110585379A (en) | External application medicine for treating dermatitis | |
CN101983681A (en) | Medicament for treating abnormal leucorrhea | |
CN108578549B (en) | Medicine for treating acne and application thereof | |
CN1058177C (en) | Traditional Chinese medicine plaster for treatment of mastosis | |
CN112439006A (en) | Traditional Chinese medicine composition and tincture for treating intractable neurodermatitis and preparation method thereof | |
CN1176699C (en) | Lupus treating medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Zhou Jinghe Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice |
Addressee: Zhou Jinghe Document name: Notification of Termination of Patent Right |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080109 Termination date: 20110910 |